The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $63.38

Today's change-2.35 -3.57%
Updated June 27 11:31 AM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $63.38

Today's change-2.35 -3.57%
Updated June 27 11:31 AM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc down (U.S.)$2.35

LifePoint Health Inc is sharply lower today, dropping (U.S.)$2.35 or 3.57% to (U.S.)$63.38. Over the last five days, shares have lost 3.73% and are down 13.66% for the last year to date. This security has underperformed the S&P 500 by 19.58% during the last year.

Key company metrics

  • Open(U.S.) $65.08
  • Previous close(U.S.) $65.72
  • High(U.S.) $65.08
  • Low(U.S.) $63.00
  • Bid / Ask(U.S.) $63.36 / (U.S.) $63.45
  • YTD % change-13.66%
  • Volume119,264
  • Average volume (10-day)367,443
  • Average volume (1-month)356,587
  • Average volume (3-month)386,439
  • 52-week range(U.S.) $58.20 to (U.S.) $88.18
  • Beta0.83
  • Trailing P/E17.64×
  • P/E 1 year forward17.54×
  • Forward PEG3.37×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.59
Updated June 27 11:31 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.16%

Based on its net profit margin of 3.16%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.79%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1,5811,3711,3101,270
Total other revenue--------
Total revenue1,5811,3711,3101,270
Gross profit553500478470
Total cost of revenue1,028871832801
Total operating expense1,5441,2881,2371,192
Selling / general / administrative356286274263
Research & development--------
Depreciation / amortization86727069
Interest expense (income), net operating--------
Unusual expense (income)1020
Other operating expenses, total35303132
Operating income37837278
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax37877278
Income after tax24554650
Income tax, total13312628
Net income22534446
Total adjustments to net income--------
Net income before extra. items22534446
Minority interest-2-2-2-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22534446
Inc. avail. to common incl. extra. items22534446
Diluted net income22534446
Dilution adjustment--------
Diluted weighted average shares45464646
Diluted EPS excluding extraordinary itemsvalue per share0.491.160.941.00
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.501.160.971.00